Build status - In Progress

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
Recruiting
18 years - 99 years
All
Phase 2
52 participants needed
1 Location

Brief description of study

This trial studies how well pevonedistat alone or in combination with chemotherapy (paclitaxel and carboplatin) works in treating patients with bile duct cancer of the liver. Pevonedistat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: liver cancer,cancer,Metastatic Cholangiocarcinoma
  • Age: 18 years - 99 years
  • Gender: All

Male or Female, Age 18 or older with histologically confirmed intrahepatic cholangiocarcinoma or biphasic hepatocellular carcinoma and cholangiocarcinom

Updated on 04 Aug 2024. Study ID: 843850

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center